ACLX·03940C100·US·equity·Healthcare - Biotechnology-Activist
ACLX (ARCELLX INC) is held by 111 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($453M), Pentwater Capital Management LP ($329.5M), FIL Ltd ($268.6M). Net institutional sentiment: Mixed.
See how ACLX's score breaks down across 4 SEC sources
Showing 1-20 of 146
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer